SE333126B - Saett att framstaella ett nytt antibiotiskt aemne kallat adriamycin,dess aglykon och dess hydroklorid genom odling av en ny mikroorganism kallad streptomyces peucetius var caesius - Google Patents

Saett att framstaella ett nytt antibiotiskt aemne kallat adriamycin,dess aglykon och dess hydroklorid genom odling av en ny mikroorganism kallad streptomyces peucetius var caesius

Info

Publication number
SE333126B
SE333126B SE5098/68A SE509868A SE333126B SE 333126 B SE333126 B SE 333126B SE 5098/68 A SE5098/68 A SE 5098/68A SE 509868 A SE509868 A SE 509868A SE 333126 B SE333126 B SE 333126B
Authority
SE
Sweden
Prior art keywords
called
new
caesius
aglycon
hydrochloride
Prior art date
Application number
SE5098/68A
Other languages
English (en)
Swedish (sv)
Inventor
F Arcamone
G Cassinelli
A Marco
M Gaetani
Original Assignee
Farma Italia Soc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farma Italia Soc filed Critical Farma Italia Soc
Publication of SE333126B publication Critical patent/SE333126B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE5098/68A 1967-04-18 1968-04-17 Saett att framstaella ett nytt antibiotiskt aemne kallat adriamycin,dess aglykon och dess hydroklorid genom odling av en ny mikroorganism kallad streptomyces peucetius var caesius SE333126B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1505667 1967-04-18

Publications (1)

Publication Number Publication Date
SE333126B true SE333126B (sv) 1971-03-08

Family

ID=11146217

Family Applications (1)

Application Number Title Priority Date Filing Date
SE5098/68A SE333126B (sv) 1967-04-18 1968-04-17 Saett att framstaella ett nytt antibiotiskt aemne kallat adriamycin,dess aglykon och dess hydroklorid genom odling av en ny mikroorganism kallad streptomyces peucetius var caesius

Country Status (15)

Country Link
US (1) US3590028A (oth)
AT (1) AT276630B (oth)
BE (1) BE713773A (oth)
CH (1) CH496091A (oth)
DE (1) DE1770204B1 (oth)
DK (1) DK118652B (oth)
ES (1) ES352842A1 (oth)
FR (2) FR1583289A (oth)
GB (1) GB1161278A (oth)
IL (1) IL29813A (oth)
NL (1) NL6804925A (oth)
NO (1) NO124883B (oth)
SE (1) SE333126B (oth)
SU (1) SU378026A3 (oth)
YU (1) YU33730B (oth)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3965088A (en) * 1967-10-18 1976-06-22 Rhone-Poulenc S.A. Naphthacene derivatives
US3957755A (en) * 1967-10-18 1976-05-18 Rhone-Poulenc S.A. Naphthacene derivatives
SE400975B (sv) * 1971-01-20 1978-04-17 Rhone Poulenc Sa Forfarande for framstellning av ett nytt antibiotikum, benemnt 27 706 rp
FR2160716A1 (en) * 1971-11-23 1973-07-06 Rhone Poulenc Sa Antibiotics duborimycin and 27706rp - by reduction of daunorubicin and adriamycin
GB1457632A (en) * 1974-03-22 1976-12-08 Farmaceutici Italia Adriamycins
US3976667A (en) * 1975-06-19 1976-08-24 The Upjohn Company Steffimycinone, 7-deoxysteffimycinone and derivatives
US4012448A (en) * 1976-01-15 1977-03-15 Stanford Research Institute Synthesis of adriamycin and 7,9-epiadriamycin
ES444380A1 (es) * 1976-01-16 1977-06-16 Gosalvez Mario Un procedimiento para preparar derivados metalicos antraci- clinicos.
US4039736A (en) * 1976-04-15 1977-08-02 Bristol-Myers Company Antibiotic compounds marcellomycin and musettamycin
GB1509875A (en) * 1976-06-14 1978-05-04 Farmaceutici Italia Optically active anthracyclinones and anthracycline glycosides
US4192915A (en) * 1976-08-16 1980-03-11 Bristol-Myers Company Anthracycline glycosides from streptomyces
US4209588A (en) * 1976-10-05 1980-06-24 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Process for producing new antitumor anthracycline antibiotics
NL176004C (nl) * 1976-10-05 1985-02-01 Microbial Chem Res Found Werkwijze ter bereiding van geneesmiddelen met antitumorwerking op basis van anthracycline glycosiden en werkwijze ter bereiding van daartoe dienende anthracycline glycosiden.
US4112071A (en) * 1977-01-10 1978-09-05 Bristol-Myers Company Antibiotic complex
US4089872A (en) * 1977-03-09 1978-05-16 The Upjohn Company Antibiotics steffimycinol and 7-deoxysteffimycinol and process for preparing the same
US4246399A (en) * 1977-03-21 1981-01-20 Interx Research Corporation Complexes of doxorubicin exhibiting enhanced stability
US4077844A (en) * 1977-03-30 1978-03-07 The Upjohn Company Process for preparing steffimycinol
NL7900869A (nl) * 1978-02-09 1979-08-13 Erba Farmitalia Anthracyclinenantibiotica.
US4248970A (en) * 1978-05-30 1981-02-03 Bristol-Myers Company Antibiotic complex producing bacterial culture
US4196127A (en) * 1978-06-01 1980-04-01 Research Corporation Anthracyclines
US4201773A (en) * 1978-07-26 1980-05-06 The United States Of America As Represented By The Department Of Health, Education And Welfare 7-O-(2,6-Dideoxy-α-L-lyxo-hexopyranosyl)-daunomycinone, desmethoxy daunomycinone, adriamycinone, and carminomycinone
US4303785A (en) * 1978-08-05 1981-12-01 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Antitumor anthracycline antibiotics
IT1196402B (it) * 1978-11-21 1988-11-16 Erba Farmitalia Antibiotici antitumorali
JPS5648893A (en) * 1979-09-07 1981-05-02 Sanraku Inc Preparation of anthracycline glycoside
US4348388A (en) * 1980-04-02 1982-09-07 G.D. Searle & Co. 11-Amino-11-deoxydaunorubicin and analogs
JPS56156300A (en) * 1980-04-26 1981-12-02 Microbial Chem Res Found Novel preparative method of anthracyclin derivative
JPS5750994A (en) * 1980-09-12 1982-03-25 Microbial Chem Res Found Novel antibiotic mf266 substance and its preparation
JPS5756494A (en) * 1980-09-22 1982-04-05 Microbial Chem Res Found New anthracyclin derivative
JPS57163393A (en) * 1981-03-27 1982-10-07 Microbial Chem Res Found Novel anthracyclin derivative and its preparation
US4374979A (en) * 1981-04-27 1983-02-22 The University Of Kansas Endowment Association Regiospecific synthesis of anthracyclinone compounds such as daunomycinone
US4471052A (en) * 1982-01-18 1984-09-11 Adria Laboratories, Inc. Biosynthesis of simplified anthracyclines
GB2125030B (en) * 1982-08-13 1986-11-26 Erba Farmitalia Naphthacenequinone synthesis
US4562177A (en) * 1982-08-17 1985-12-31 The Ohio State University Research Foundation 3'-Amino-2' halo-anthracycline antibiotics
US4548927A (en) * 1983-05-25 1985-10-22 Eaton John W Method and agents for raising animal tolerance to oxidant stress-inducing antibiotics
GB8426672D0 (en) * 1984-10-22 1984-11-28 Erba Farmitalia Pharmaceutical compositions
US4610977A (en) * 1985-04-08 1986-09-09 The University Of Tennessee Research Corporation N-alkyl and N-benzyl adriamycin derivatives
GB8519452D0 (en) * 1985-08-02 1985-09-11 Erba Farmitalia Injectable solutions
US5124317A (en) * 1985-08-02 1992-06-23 Farmitalia Carlo Erba S.P.A. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US4863739A (en) * 1987-05-19 1989-09-05 Board Of Regents, The University Of Texas System Liposome compositions of anthracycline derivatives
EP0396626A1 (en) * 1988-01-19 1990-11-14 Board Of Regents, The University Of Texas System Glycosides, liposomal compositions thereof, and methods for their use
GB8812697D0 (en) * 1988-05-27 1988-06-29 Erba Carlo Spa Isolation & characterisation of genes resistant to anthracycline antibiotics
US5220001A (en) * 1989-10-25 1993-06-15 Zaidan Hojim Biseibutsu Dong-A Pharm Co. Anthracycline glycoside derivatives
KR100211417B1 (ko) * 1990-11-30 1999-10-01 유충식 L-탈로피라노시드 유도체 및 그의 제조방법
DE4417865A1 (de) * 1994-05-20 1995-11-23 Behringwerke Ag Kombination von Tumornekrose-induzierenden Substanzen mit Substanzen, die durch Nekrosen aktiviert werden, zur selektiven Tumortherapie
ES2299177T3 (es) * 1995-05-10 2008-05-16 Kyowa Hakko Kogyo Co., Ltd. Conjugados de citotoxinas que contienen dipeptidos.
DE69738815D1 (de) 1996-10-15 2008-08-14 Searle Llc Verwendung von Cyclooxygenase-2 Inhibitoren zur Behandlung und Vorbeugung von Neoplasia
US20030100532A1 (en) * 1997-02-14 2003-05-29 Gary S. Jacob Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections
US5948896A (en) * 1997-08-13 1999-09-07 Gem Pharmaceuticals Processes for preparing 13-deoxy anthracycline derivatives
CA2309321A1 (en) 1997-11-10 1999-05-20 G.D. Searle & Co. Use of alkylated iminosugars to treat multidrug resistance
GB9727546D0 (en) * 1997-12-31 1998-03-18 Pharmacia & Upjohn Spa Anthracycline glycosides
US6689759B1 (en) 1998-02-12 2004-02-10 G. D. Searle & Co. Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy
KR20010040937A (ko) 1998-02-12 2001-05-15 윌리암스 로저 에이 간염 바이러스 감염의 치료를 위한 ｎ-치환된1,5-디데옥시-1,5-이미노-ｄ-글루시톨 화합물의 용도
WO2000023453A1 (fr) * 1998-10-16 2000-04-27 Mercian Corporation Cristallisation de chlorhydrate de doxorubicine
WO2001008672A2 (en) 1999-02-12 2001-02-08 G.D. Searle & Co. Glucamine compounds for treating hepatitis virus infections
CA2362914C (en) * 1999-02-12 2009-04-14 G.D. Searle & Co. Use of substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections
WO2001060366A1 (en) * 2000-02-14 2001-08-23 Pharmacia Corporation Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections
US20060079463A1 (en) * 2003-05-20 2006-04-13 Zhong Hong J Anticancer compositions comprising methenamine
JP2007507523A (ja) * 2003-10-02 2007-03-29 セフアロン・インコーポレーテツド 置換インドール誘導体
US8436190B2 (en) 2005-01-14 2013-05-07 Cephalon, Inc. Bendamustine pharmaceutical compositions
US20070004653A1 (en) * 2005-05-11 2007-01-04 Roberto Arosio Stable lyophilized anthracycline glycosides
AU2007307489A1 (en) * 2006-10-06 2008-04-17 Takeda Pharmaceutical Company Limited Combination drug
US8034905B2 (en) 2007-11-09 2011-10-11 Affitech Research, AS Anti-VEGF antibody compositions and methods
AR072777A1 (es) 2008-03-26 2010-09-22 Cephalon Inc Formas solidas de clorhidrato de bendamustina
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
EP2189158A1 (en) * 2008-11-20 2010-05-26 DKFZ Deutsches Krebsforschungszentrum, Stiftung des Öffentlichen Rechts Combination of rocaglamide and apoptosis inducing substances for the treatment of cancer
US8716262B2 (en) * 2008-12-23 2014-05-06 Gilead Pharmasset Llc Nucleoside phosphoramidates
EP2376514A2 (en) * 2008-12-23 2011-10-19 Pharmasset, Inc. Nucleoside analogs
WO2010075554A1 (en) 2008-12-23 2010-07-01 Pharmasset, Inc. Synthesis of purine nucleosides
RS54368B1 (sr) 2010-03-31 2016-04-28 Gilead Pharmasset Llc Kristalni (s)-izopropil 2-(((s)-(((2r,3r,4r,5r)-5-(2,4-diokso-3,4-dihidropirimidin-1-(2h)-il)-4-fluoro-3-hidroksi-4-metiltetrahidrofuran-2-il)metoksi)(fenoksi)fosforil)amino)propanoat
DK2582847T3 (en) 2010-06-18 2016-12-19 Myriad Genetics Inc METHODS AND MATERIALS TO ASSESS loss of heterozygosity
EP3109325B1 (en) 2010-08-24 2018-12-26 Dana-Farber Cancer Institute, Inc. Methods for predicting anti-cancer response
CN102363755B (zh) * 2011-05-21 2013-04-03 浙江海正药业股份有限公司 一种链霉菌及其生产阿霉素的方法
CA2839210A1 (en) 2011-06-17 2012-12-20 Myriad Genetics, Inc. Methods and materials for assessing allelic imbalance
FI2794907T4 (fi) 2011-12-21 2023-03-27 Menetelmiä ja materiaaleja heterotsygoottisuuden menettämisen arvioimiseksi
NZ628813A (en) 2012-02-23 2015-10-30 Univ Denmark Tech Dtu Methods for predicting anti-cancer response
JP6104287B2 (ja) * 2012-03-06 2017-03-29 天津和美生物技術有限公司 四環系アントラキノン誘導体
US11091808B2 (en) 2012-06-07 2021-08-17 Institut Curie Methods for detecting inactivation of the homologous recombination pathway (BRCA1/2) in human tumors
CN103087124B (zh) * 2012-11-21 2016-01-13 浙江海正药业股份有限公司 一种制备阿霉素的方法
US10308986B2 (en) 2013-03-14 2019-06-04 Children's Medical Center Corporation Cancer diagnosis, treatment selection and treatment
JP6532860B2 (ja) * 2013-03-29 2019-06-19 アボサイエンス、リミテッド、ライアビリティー、カンパニーＡｖｏｓｃｉｅｎｃｅ， Ｌｌｃ 癌、神経障害及び線維性障害の治療のための、脂質フラン、ピロール及びチオフェン化合物
US20140363521A1 (en) 2013-04-05 2014-12-11 Myriad Genetics, Inc. Methods and materials for assessing homologous recombination deficiency
US11149316B2 (en) 2013-12-09 2021-10-19 Institut Curie Methods for detecting inactivation of the homologous recombination pathway (BRCA1/2) in human tumors
CN104774229A (zh) * 2014-01-10 2015-07-15 浙江华谱新创科技有限公司 一种阿霉素及其衍生物的制备方法
ES3039109T3 (en) 2014-08-15 2025-10-17 Myriad Genetics Inc Methods and materials for assessing homologous recombination deficiency
US20170312246A1 (en) 2016-04-27 2017-11-02 Avoscience, Llc Lipidic furan, pyrrole, and thiophene compounds for use in the treatment of atrophic vaginitis
CN107773556B (zh) * 2016-08-26 2020-08-18 广州安好医药科技有限公司 一种具有抗肿瘤药物功效的联合用药物
EP4141127B1 (en) 2021-08-30 2024-10-09 Zentrum Familiärer Brust- und Eierstockkrebs Universitätsklinik Köln Method for assessing homologous recombination deficiency in ovarian cancer cells

Also Published As

Publication number Publication date
US3590028A (en) 1971-06-29
CH496091A (de) 1970-09-15
YU71568A (en) 1977-08-31
SU378026A3 (oth) 1973-04-17
NO124883B (oth) 1972-06-19
IL29813A (en) 1971-04-28
YU33730B (en) 1978-02-28
BE713773A (fr) 1968-10-17
NL6804925A (oth) 1968-10-21
ES352842A1 (es) 1969-08-01
FR7406M (fr) 1969-11-03
FR1583289A (fr) 1969-10-24
IL29813A0 (en) 1968-06-20
DK118652B (da) 1970-09-21
AT276630B (de) 1969-11-25
DE1770204B1 (de) 1971-12-23
GB1161278A (en) 1969-08-13

Similar Documents

Publication Publication Date Title
SE333126B (sv) Saett att framstaella ett nytt antibiotiskt aemne kallat adriamycin,dess aglykon och dess hydroklorid genom odling av en ny mikroorganism kallad streptomyces peucetius var caesius
BE853369A (fr) Nouvel antibiotique du type anthracycline et son procede de preparation
ES472306A1 (es) Un procedimiento para la produccion de un glicosido de an- traciclina
SE390542B (sv) Framstellning av ett nytt antibiotikum kallat a-2315 genom odling av en ny stam av actinoplanes philippinensis (nrrl 5462)
SE384690B (sv) Framstellning av antibiotikum a 16886 i och/eller antibiotikum a 16886 ii genom odling av streptomyces clavuligerus nrrl 3585
FI48585C (fi) Tapa valmistaa terapeuttisesti vaikuttavia 4'-demetyyliepipodofyllotok siiniglukosidin johdannaisia.
SE420214B (sv) Framstellning av ett nytt antibiotikum benemt fortimicin b genom odling av micromonospora olivoasterospora atcc 21819, 31009 eller 31010 samt isolering
FR1466268A (fr) Nouvel antibiotique préparé par culture des streptomyces et son procédé de fabrication
SE387658B (sv) Framstellning av nytt antibiotikum betecknat myc-8003 genom odling av ny mikroorganism benemd streptomyces ramocissimus
SE432780B (sv) Sett att framstella ett nytt antibiotikum, n-acetyltienamycin och salter derav, genom odling av streptomyces cattleya nrrl 8057
CA737910A (en) Antibiotic by cultivation of streptomyces with ethionine
SE390541B (sv) Framstellning av en antibiotiskt aktiv produkt, dess komponenter hittills okenda antibiotikum g-52 och kenda sisomicin genom odling av en mikroorganism benemnd micromonospora zionensis
IT1045476B (it) Tiopertina antibiotica ottenuta in mezzo nutriente acquoso da streptomyces tateyamensis atoo21384
AU426655B2 (en) New antibiotic and its preparation by culture of streptomyces
SE387364B (sv) Framstellning av det kenda antibiotikummet linkomycin genom odling av en stam av streptomyces espinosus dietz sp.n. deponerad som nrrl 3890
SE399907B (sv) Framstellning av en kend forening bl a benemnd bicyklomycin och antibiotikum nr 5879 genom odling av en ny mikroorganism benemnd streptomyces aizunensis deponerad som ferm-p no 1501
CA532613A (en) Isolation of antibiotic produced by streptomyces aureofaciens
IT7850291A0 (it) Antibiotico della antraciclina e relativo procedimento di produzione
CA746874A (en) Antibiotic by streptomyces lincolnensis
CA731117A (en) Antibiotic by streptomyces pactum
CA745181A (en) Manufacture of 1-cyano-1,3-butadiene
CA683292A (en) Antibiotic by streptomyces spectabilis
CA818462A (en) Antibiotic production of coumermycin by streptomyces rishiriensis
FR1499875A (fr) Nouveaux antibiotiques obtenus par culture de streptomyces caelestis et leurs procédés de préparation
FR2351659A1 (fr) Nouveaux composes antibiotiques, leurs preparations et leurs applications